These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 25416828)

  • 21. Comparison of elective stenting of severe vs moderate intracranial atherosclerotic stenosis.
    Jiang WJ; Xu XT; Du B; Dong KH; Jin M; Wang QH; Ma N
    Neurology; 2007 Feb; 68(6):420-6. PubMed ID: 17283316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long term clinical and angiographic outcomes with the Wingspan stent for treatment of symptomatic 50-99% intracranial atherosclerosis: single center experience in 51 cases.
    Wolfe TJ; Fitzsimmons BF; Hussain SI; Lynch JR; Zaidat OO
    J Neurointerv Surg; 2009 Jul; 1(1):40-3. PubMed ID: 21994104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of stent versus medical therapy for symptomatic patients with intracranial atherosclerotic stenosis: A meta-analysis.
    Zhang Q; Dong K; Song H
    J Neurol Sci; 2017 Jan; 372():272-278. PubMed ID: 28017227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of high risk symptomatic intracranial atherosclerosis with balloon mounted coronary stents and Wingspan stents: single center experience over a 10 year period.
    Tarlov N; Jahan R; Saver JL; Sayre JW; Ali LK; Kim D; Duckwiler GR; Tateshima S; Viñuela F; Liebeskind DS
    J Neurointerv Surg; 2012 Jan; 4(1):34-9. PubMed ID: 21990460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Consensus conference on intracranial atherosclerotic disease: rationale, methodology, and results.
    Qureshi AI; Feldmann E; Gomez CR; Johnston SC; Kasner SE; Quick DC; Rasmussen PA; Suri MF; Taylor RA; Zaidat OO
    J Neuroimaging; 2009 Oct; 19 Suppl 1():1S-10S. PubMed ID: 19807850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early and intermediate-term outcomes with drug-eluting stents in high-risk patients with symptomatic intracranial stenosis.
    Qureshi AI; Kirmani JF; Hussein HM; Harris-Lane P; Divani AA; Suri MF; Janjua N; Alkawi A
    Neurosurgery; 2006 Nov; 59(5):1044-51; discussion 1051. PubMed ID: 17143239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imaging and clinical predictors of unfavorable outcome in medically treated symptomatic intracranial atherosclerotic disease.
    Kate M; Sylaja PN; Kesavadas C; Thomas B
    J Stroke Cerebrovasc Dis; 2014; 23(5):973-8. PubMed ID: 24119624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intracranial angioplasty with Gateway-Wingspan system for symptomatic atherosclerotic stenosis: preliminary results of 27 Chinese patients.
    Zhao ZW; Deng JP; He SM; Qin HZ; Gao L; Gao GD
    Surg Neurol; 2009 Dec; 72(6):607-11; discussion 611. PubMed ID: 20082830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebral Hemodynamics Underlying Artery-to-Artery Embolism in Symptomatic Intracranial Atherosclerotic Disease.
    Feng X; Fang H; Ip BYM; Chan KL; Li S; Tian X; Zheng L; Liu Y; Lan L; Liu H; Abrigo J; Ma SH; Fan FSY; Ip VHL; Soo YOY; Mok VCT; Song B; Leung TW; Xu Y; Leng X
    Transl Stroke Res; 2024 Jun; 15(3):572-579. PubMed ID: 36897543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracranial atherosclerosis.
    Qureshi AI; Caplan LR
    Lancet; 2014 Mar; 383(9921):984-98. PubMed ID: 24007975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A single-center study of Wingspan stents for symptomatic atherosclerotic stenosis of the middle cerebral artery.
    Zhang L; Huang Q; Zhang Y; Deng B; Liu J; Hong B; Xu Y; Zhao W
    J Clin Neurosci; 2013 Mar; 20(3):362-6. PubMed ID: 23228656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concurrent comparison of outcomes of primary angioplasty and of stent placement in high-risk patients with symptomatic intracranial stenosis.
    Qureshi AI; Hussein HM; El-Gengaihy A; Abdelmoula M; K Suri MF
    Neurosurgery; 2008 May; 62(5):1053-60; discussion 1060-2. PubMed ID: 18580803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Staged stent-assisted angioplasty for symptomatic intracranial vertebrobasilar artery stenosis.
    Levy EI; Hanel RA; Bendok BR; Boulos AS; Hartney ML; Guterman LR; Qureshi AI; Hopkins LN
    J Neurosurg; 2002 Dec; 97(6):1294-301. PubMed ID: 12507126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intracranial Atherosclerosis: A Disease of Functional, not Anatomic Stenosis? How Trans-Stenotic Pressure Gradients Can Help Guide Treatment.
    Zanaty M; Rossen JD; Roa JA; Nakagawa D; Hudson JS; Kasab SA; Limaye K; Asi K; Dandapat S; Jabbour P; Samaniego EA; Hasan DM
    Oper Neurosurg (Hagerstown); 2020 Jun; 18(6):599-605. PubMed ID: 31848612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intracranial atherosclerosis: current concepts.
    Arenillas JF
    Stroke; 2011 Jan; 42(1 Suppl):S20-3. PubMed ID: 21164126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of intracranial atherosclerotic stenosis.
    Turan TN; Chimowitz MI
    Rev Neurol Dis; 2008; 5(3):117-24. PubMed ID: 18838951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design of the Vitesse Intracranial Stent Study for Ischemic Therapy (VISSIT) trial in symptomatic intracranial stenosis.
    Zaidat OO; Castonguay AC; Fitzsimmons BF; Woodward BK; Wang Z; Killer-Oberpfalzer M; Wakhloo A; Gupta R; Kirshner H; Eliasziw M; Thomas Megerian J; Shetty S; Yoklavich Guilhermier M; Barnwell S; Smith WS; Gress DR;
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1131-9. PubMed ID: 23261207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early aggressive medical management for patients with symptomatic intracranial stenosis.
    Nahab F; Kingston C; Frankel MR; Dion JE; Cawley CM; Mitchell B; Hammonds LP; Ayala L; Tong FC
    J Stroke Cerebrovasc Dis; 2013 Jan; 22(1):87-91. PubMed ID: 21795066
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreased levels of angiogenic growth factors in intracranial atherosclerotic disease despite severity-related increase in endothelial progenitor cell counts.
    Massot A; Navarro-Sobrino M; Penalba A; Arenillas JF; Giralt D; Ribó M; Molina CA; Alvarez-Sabín J; Montaner J; Rosell A
    Cerebrovasc Dis; 2013; 35(1):81-8. PubMed ID: 23429001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lesion location, stability, and pretreatment management: factors affecting outcomes of endovascular treatment for vertebrobasilar atherosclerosis.
    Alexander MD; Rebhun JM; Hetts SW; Kim AS; Nelson J; Kim H; Amans MR; Settecase F; Dowd CF; Halbach VV; Higashida RT; Cooke DL
    J Neurointerv Surg; 2016 May; 8(5):466-70. PubMed ID: 25795438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.